Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Debinski

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Critical Reviews in Oncogenesis|April 14, 1999
An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected linkW Debinski
Annals of the New York Academy of Sciences|February 10, 2000
Recombinant cytotoxins specific for cancer cellsW Debinski
Cancer Research|July 17, 2001
Correspondence re: B. H. Joshi et al., interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. Cancer Res., 60: 1168-1172, 2000W Debinski
Cancer Research|October 1, 1992
Monovalent immunotoxin containing truncated form of Pseudomonas exotoxin as potent antitumor agentW Debinski, I Pastan
Critical Reviews in Oncogenesis|May 5, 2000
Cancer genetics/epigenetics and the X chromosome: possible new links for malignant glioma pathogenesis and immune-based therapiesA Mintz, W Debinski
Journal of Neurochemistry|March 1, 1990
Atrial natriuretic peptide content in rat superior cervical ganglion after denervation and axotomyW Debinski, O Kuchel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1995
Recombinant F(ab') C242-Pseudomonas exotoxin, but not the whole antibody-based immunotoxin, causes regression of a human colorectal tumor xenograftW Debinski, I Pastan
Bioconjugate Chemistry|January 1, 1994
An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxinW Debinski, I Pastan
The Journal of Biological Chemistry|October 9, 1999
Mutants of interleukin 13 with altered reactivity toward interleukin 13 receptorsJ P Thompson, W Debinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Retargeting interleukin 13 for radioimmunodetection and radioimmunotherapy of human high-grade gliomasW Debinski, J P Thompson
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Critical Reviews in Oncogenesis|April 14, 1999
An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected linkW Debinski
Annals of the New York Academy of Sciences|February 10, 2000
Recombinant cytotoxins specific for cancer cellsW Debinski
Cancer Research|July 17, 2001
Correspondence re: B. H. Joshi et al., interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. Cancer Res., 60: 1168-1172, 2000W Debinski
Cancer Research|October 1, 1992
Monovalent immunotoxin containing truncated form of Pseudomonas exotoxin as potent antitumor agentW Debinski, I Pastan
Critical Reviews in Oncogenesis|May 5, 2000
Cancer genetics/epigenetics and the X chromosome: possible new links for malignant glioma pathogenesis and immune-based therapiesA Mintz, W Debinski
Journal of Neurochemistry|March 1, 1990
Atrial natriuretic peptide content in rat superior cervical ganglion after denervation and axotomyW Debinski, O Kuchel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1995
Recombinant F(ab') C242-Pseudomonas exotoxin, but not the whole antibody-based immunotoxin, causes regression of a human colorectal tumor xenograftW Debinski, I Pastan
Bioconjugate Chemistry|January 1, 1994
An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxinW Debinski, I Pastan
The Journal of Biological Chemistry|October 9, 1999
Mutants of interleukin 13 with altered reactivity toward interleukin 13 receptorsJ P Thompson, W Debinski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Retargeting interleukin 13 for radioimmunodetection and radioimmunotherapy of human high-grade gliomasW Debinski, J P Thompson
Pageof 8